Cholinesterase inhibitors

H 67 Pill - yellow capsule-shape, 18mm

Pill with imprint H 67 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Aurobindo Pharma Limited.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-H 67-1.5 mg-Yellow-Capsule-shape

Rivastigmine transdermal
Generic Name: rivastigmine transdermal [ riv-a-stig-meen ]
Imprint: H 67
Strength: 1.5 mg
Color: Yellow
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Cholinesterase inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 65862-0648
Inactive Ingredients: Silicon dioxide, Hypromellose 2910 (5 mPa.s), Magnesium stearate, Microcrystalline cellulose, Gelatin, Ferric oxide red, Ferric oxide yellow, Sodium lauryl sulfate, Titanium dioxide, Ferrosoferric oxide, Potassium hydroxide, Propylene glycol, Shellac, Ammonia,
Latest News
Related Drugs